Geometry Dash APK Hill Climb Racing APK
15.6 F
New York
Friday, January 21, 2022

CymaBay Therapeutics (NASDAQ:CBAY) Surges Following Independent Findings Of Its Drug Seladelpar

Must read

88 Energy Limited Ltd (EEENF) Update: Continues Climbing on Significant Volume

Investors who might be looking for stocks that have made considerable gains in recent weeks could consider having a closer look at...

Victory Resources Corporation (OTCMKTS:VRCFF) Stock Rockets After Announcing A New Acquisition

Nowadays, lithium is in huge demand across several industries and hence, it the rally in the Victory Resources Corporation (OTCMKTS:VRCFF) stock the...

Healthier Choices Management Corp (OTCMKTS:HCMC) Heats Up: WallStreetBets at it Again

At the mid-point of the trading week, it is often prundent for investors to take stock of the market and take a...

Is Enzolytics Inc (OTCMKTS:ENZC) Making All The Right Moves in 2021

When a stock makes massive gains over a reasonable period of time, then it is necessary for investors to perhaps looking into...

Since last week CymaBay Therapeutics (NASDAQ:CBAY) stock has gained around 143% following positive news regarding orphan drug Seladelpar.

CymBay reconsidering initiating seladelpar clinical trials

CymBay put off the phase 2b study for seladelpar on non-alcoholic steatohepatitis (NASH) last November. This was because of safety concerns that emerged after pathologists established that there was liver tissue damage in subjects. However, last week there was positive development after a panel of experts overturned the previous findings that indicated that the drug resulted in liver damage. The experts proposed for the restart of the clinical development of seladelpar pending FDA approval.

CymBay CEO, Sujal Shah indicated that they are yet to discuss the full results of the company’s investigation or the conclusions of the panel of experts with the FDA. He added that the company is planning to re-engage the FDA as soon as possible.

Approval of seladelpar will be a huge win for CymBay

The company is not making money for now and it is not producing positive net income because it does not generate any revenue. This is a small-sized company with only 36 employees which can help it keep costs down but could be a challenge if the FDA approves seladelpar and the company wishes to commence production.

Another issue of concern is that it is likely that the FDA might not agree with the findings of experts to approve clinical trials. Similarly even if the clinical trials commence, the efficiency of seladelpar against NASH could not be strong or the side effects of the drug might not be worth the risk.

However despite the challenges the drug has potential owing to the large number of Americans affected by NASH. Most importantly there is no FDA approved NASH treatment and thus if seladelar is the first this could be a huge score.

Also CymBay says there are other uses of seladelpar against various inflammatory liver conditions. It is also being considered for use in the treatment of primary biliary cholangitis. Sign-up below for continuing coverage on CBAY and other breakout stocks.

Latest article

iQSTEL Inc (OTCMKTS:IQST) Stock Makes a Big Move: Jumps 45% In a Week

In the past week, iQSTEL Inc (OTCMKTS: IQST) has emerged as a point of focus among a large number of investors and...

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet.
SmsVerifyer.com Affordable best sms verification service